Literature DB >> 12015711

On the origin and spread of Dupuytren's disease.

Robert M McFarlane1.   

Abstract

The first author to suggest an origin and spread of Dupuytren's disease was Early who wrote in 1962, "If one postulates the condition as having arisen in one particular racial group (the Nordic for example) then the variable distribution in other parts of the world might be explained on the basis of migration from that group." Dupuytren's disease is currently called a Viking disease on the assumption that the disease was spread to Europe and the British Isles during the Viking Age of the 9th to the 13th centuries. From a literature search, it is proposed that Dupuytren's disease existed in Europe earlier than the Viking Age and originated much earlier in prehistory.

Mesh:

Year:  2002        PMID: 12015711     DOI: 10.1053/jhsu.2002.32334

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  11 in total

1.  Postoperative management of Dupuytren's disease with topical nitroglycerin.

Authors:  Patrick I Emelife; Russell E Kling; Ronit Wollstein
Journal:  Can J Plast Surg       Date:  2012

2.  Role of the HLA System in the Pathogenesis of Dupuytren's Disease.

Authors:  Sara McCarty; Farhatullah Syed; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2010-02-09

3.  Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.

Authors:  Latha Satish; David B O'Gorman; Sandra Johnson; Christina Raykha; Bing Siang Gan; James H-C Wang; Sandeep Kathju
Journal:  Cell Stress Chaperones       Date:  2013-01-06       Impact factor: 3.667

Review 4.  Dupuytren's Disease-Etiology and Treatment.

Authors:  Mike Ruettermann; Robert Michael Hermann; Karl Khatib-Chahidi; Paul M N Werker
Journal:  Dtsch Arztebl Int       Date:  2021-11-19       Impact factor: 8.251

5.  Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology.

Authors:  Sandip Hindocha; Duncan Angus McGrouther; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2009-01-15

6.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

7.  Dupuytren's Disease: Review of the Current Literature.

Authors:  Morsi Khashan; Peter J Smitham; Wasim S Khan; Nicholas J Goddard
Journal:  Open Orthop J       Date:  2011-07-28

8.  N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-beta signalling.

Authors:  Jürgen Kopp; Harun Seyhan; Bastian Müller; Johanna Lanczak; Elke Pausch; Axel M Gressner; Steven Dooley; R E Horch
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

9.  The Epidemiology of Dupuytren's Disease in Korea: a Nationwide Population-based Study.

Authors:  Kwang-Hyun Lee; Joo-Hak Kim; Chang-Hun Lee; Sung-Jae Kim; Young-Hoon Jo; Myungsub Lee; Wan-Sun Choi
Journal:  J Korean Med Sci       Date:  2018-06-18       Impact factor: 2.153

10.  Treatment of dupuytren disease with injectable collagenase in a veteran population: a case series at the department of veterans affairs new jersey health care system.

Authors:  Aditya Sood; Paul J Therattil; Angie M Paik; Mary F Simpson; Edward S Lee
Journal:  Eplasty       Date:  2014-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.